South Korea · Delayed Price · Currency is KRW APR Co., Ltd. Earnings Call Transcripts
Fiscal Year 2026
-
Q2 2026 saw record revenue and operating profit, driven by strong growth in North America and Europe, especially in the cosmetic and beauty segment. Full-year revenue guidance was raised to KRW 3 trillion, with air freight costs expected to ease as inventory stabilizes.
-
Record Q1 2026 revenue and profit driven by strong global demand, especially in the U.S. and Europe, with robust growth in cosmetics and beauty devices. Management expects continued healthy margins and stable growth, with new product launches and retail expansion planned.
Fiscal Year 2025
-
Q4 2025 saw revenue surge 124% YoY to KRW 548B and operating profit jump 228% to KRW 130B, with annual revenue doubling to KRW 1.5T. Overseas sales now comprise 80% of total, led by the U.S., and Medicube became Korea’s top beauty brand. 2026 guidance targets KRW 2.1T revenue and 25% margin.
-
Record Q3 2025 revenue and profit were driven by global expansion, strong U.S. and Japan growth, and successful promotions. Operating margin reached 25%, with overseas sales now 80% of total revenue. Outlook remains positive, with further offline and device segment expansion planned.
-
Record Q2 sales and profit were driven by explosive overseas growth, especially in the U.S. and Japan, with operating margins reaching 26%. Management expects to exceed full-year guidance, despite tariff headwinds and increased Q4 expenses.
-
Q1 2025 saw record revenue of KRW 266 billion (+79% YoY) and operating profit of KRW 55 billion (+97% YoY), driven by global expansion, especially in the U.S. and Japan. Overseas sales now make up 71% of total revenue, with strong B2B growth in Europe and continued cost discipline.
Fiscal Year 2024
-
Record Q4 and annual sales driven by explosive growth in cosmetics and beauty devices, with overseas and B2B channels surging. 2025 targets KRW 1 trillion in sales and aggressive global expansion, supported by strong margins and shareholder returns.
-
Q3 2024 saw record revenue of KRW 174 billion (+43% YoY), driven by strong growth in beauty devices and cosmetics, with overseas sales surpassing domestic for the first time. OP margin declined due to higher transportation costs, but normalization is expected in Q4.